International Journal of Gynecology & Obstetrics
Volume 85, Issue 3 , Pages 259-266 , June 2004

Human papillomavirus infection and cervical ectopy

  • L. Rocha-Zavaleta

      Affiliations

    • Department of Molecular Biology and Biotechnology, Institute of Biomedical Research, National University of Mexico, Mexico City, Mexico
    • Corresponding Author InformationCorresponding author. Tel.: +52-55-5622-3876; fax: +52-55-5622-3855
  • ,
  • G. Yescas

      Affiliations

    • Clinic of Dysplasias, Mexican College of Colposcopists, Mexico City, Mexico
  • ,
  • R.M. Cruz

      Affiliations

    • Clinic of Dysplasias, Mexican College of Colposcopists, Mexico City, Mexico
  • ,
  • F. Cruz-Talonia

      Affiliations

    • National Center for Clinics of Dysplasias, General Hospital of Mexico, Mexico City, Mexico

Received 28 March 2003 ,Revised 6 October 2003 ,Accepted 8 October 2003.

References 

  1. Dowe G, Smikle M, King SD, Wynter H, Frederick J, Hylton-Kong T. High prevalence of genital Chlamydia trachomatis infection in women presenting in different clinical settings in Jamaica: implications for control strategies. Sex Transm Infect. 1999;75:412–416
  2. Moscicki AB, Ma Y, Holland C, Vermund SH. Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection. J Infect Dis. 2001;15:865–870
  3. Walboomers JMM, Jacobs MV, Manos MM. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–19
  4. Lungu D, Sun X, Felix J, Richart R, Silverstein S, Wright T. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. J Am Med Assoc. 1992;267:2493–2496
  5. Hagensee ME, Koutsky LA, Lee SK, Grubert T, Kuypers J, Kiviat NB, et al.  Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions. J Infect Dis. 2000;181:1234–1239
  6. Tjiong MY, Zumbach K, Schegget JT, van der Vange N, Out TA, Pawlita M, et al.  Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia. Viral Immunol. 2001;14:415–424
  7. Kaye JN, Cason J, Pakarian FB, Jewers RJ, Kell B, Bible J, et al.  Viral load as a determinant for transmission of human papillomavirus type 16 from mother to child. J Med Virol. 1994;44:415–421
  8. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells. 1989;7:209–214
  9. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, et al.  Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol. 1996;34:2095–2100
  10. Cubie HA, Plumstead M, Zhang W, de Jesus O, Duncan LA, Stanley MA. Presence of antibodies to human papillomavirus-like particles (VLPs) in 11–13-year-old schoolgirls. J Med Virol. 1998;56:210–216
  11. Kuhn L, Denny L, Pollack AE, Wright TC. Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera®. Contraception. 1999;59:363–367
  12. Jacobson DL, Peralta L, Farmer M, Graham NM, Gaydos C, Zenilman J. Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents. Sex Transm Dis. 2000;27:313–319
  13. Lazcano-Ponce E, Herrero R, Muñoz N, Cruz A, Shah KV, Alonso P, et al.  Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001;91:412–420
  14. Toon PG, Arrand JR, Wilson LP, Sharp DS. Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia. Br Med J. 1986;293:1261–1264
  15. Veress G, Csiky-Meszaros T, Czegledy J, Gergely L. Oral contraceptive use and human papillomavirus infection in women without abnormal cytological results. Med Microbiol Immunol. 1992;181:181–189
  16. Mardh PA, Tchoudomirova K, Elshibly S, Hellberg D. Symptoms and signs in single and mixed genital infections. Int J Gynecol Obstet. 1998;63:145–152
  17. Melkert PW, Hopman E, van den Brule AJ, Risse EK, Van Diest PJ, Bleker OP, et al.  Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer. 1993;53:919–923
  18. Giuliano A, Papenfuss M, Schneider A, Nour M, Hatch K. Risk factors for high-risk type human papillomavirus infection among Mexican–American women. Cancer Epidemiol Biomarkers Prev. 1999;8:615–620
  19. Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity. Sex Transm Dis. 1995;22:114–118
  20. Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, et al.  Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol. 2000;157:1055–1062
  21. Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM, et al.  High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev. 2001;10:101–106
  22. Veress G, Konya J, Csiky-Meszaros T, Czegledy J, Gergely L. Human papillomavirus DNA and anti-HPV secretory IgA antibodies in cytologically normal cervical specimens. J Med Virol. 1994;43:201–207
  23. Marais DJ, Best JM, . Rose RC, Keating P, Soeters R, Denny L, et al.  Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia. J Med Virol. 2001;65:149–154
  24. Kumar B, Gupta R, Sehgal S. Correlation of HPV antigen and type of genital warts with atypia. Genitourin Med. 1991;67:146–148
  25. Parkin M, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1990;80:827–841

PII: S0020-7292(03)00453-3

doi: 10.1016/j.ijgo.2003.10.002

International Journal of Gynecology & Obstetrics
Volume 85, Issue 3 , Pages 259-266 , June 2004